Start up. Grow up. Succeed.

News 2009


Hepa Wash GmbH (Hepa Wash) announced the successful closing of its Series-A financing round, raising €3.8m from a syndicate of new and existing private investors as well as the KfW.

KINAXO: KINAXO Completes Financing Round to Enhance Biomarker Development

KINAXO Biotechnologies GmbH announces the completion of a financing round,

ASCENDIS PHARMA: Ascendis Pharma initiates Phase I clinical study of ACP-001, a once-weekly human growth hormone product

Ascendis Pharma A/S, a privately held specialty pharmaceutical company, today announced that it has initiated a Phase I dosing study of ACP-001, a once-weekly human growth hormone prodrug.

Pieris AG: Pieris AG enters into Anticalin Collaboration with Allergan, Inc.

Pieris AG today announced that they have entered into a collaboration agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris’ proprietary Anticalin technology with Allergan’s expertise in

APEPTICO GmbH: APEPTICO GmbH closes seed financing round

APEPTICO will use the capital to push ahead the pre-clinical development.

Hepa Wash GmbH: Hepa Wash and II. Medical Department, University Hospital Rechts der Isar Awarded € 425,000 Grant from the Bayerische Forschungsstiftung (BFS) for a € 0.9 Mio Collaborative Preclinical Study on Acute Liver Failure

Hepa Wash GmbH (Hepa Wash), a medical device company developing an innovative liver support device announced today that it has received a € 425,000 grant from the Bayerische Forschungsstiftung (BFS) to test the safety and efficacy of its laboratory prototype in a preclinical animal model for acute liver failure in collaboration with the II. Medical Department, University Hospital Rechts der Isar.

Artificial Technology GmbH: Artificial Technology to Present

Artificial's founders are showing no signs of slowing down.

Kinaxo Biotechnologies GmbH: Kinaxo contributes its quantitative phosphoproteomics platform to a drug efficiency study

Kinaxo Biotechnologies GmbH announced today that it was awarded a grant by the Bavarian Research Foundation (Bayerische Forschungsstiftung) to expand applications for its quantitative phosphoproteomics platform to contribute to a drug efficacy study.

DPE Deutsche Private Equity GmbH: Deutsche Private Equity is financing the expansion of Bäckerei Wilhelm Middelberg GmbH

Funds advised by Munich-based DPE Deutsche Private Equity GmbH ("DPE"), have invested in Bäckerei Wilhelm Middelberg GmbH, Bad Iburg, Northern Germany